الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 134 |  |  |
| | | from | 134 | | |
Abstract
Sepsis is a major cause of morbidity and mortality in the neonatal period ,
inspite of extensive use of antimicrobial therapy . Sepsis related morbidity
and mortality rates are high among preterm infants , especially in the
smallest neonates.
The increased risk of severe neonatal infections in the extremely preterm
infant is thought to be attributable to immature defense mechanisms in
combination with the use of invasive treatment techniques . Intravenous
immune globulin(IVIG) ,in combination with antibiotic therapy in sepsis
,has been reported to decrease the morbidity and mortality in neonates, by
providing immediate high levels of specific antibody that maybe of
therapeutic benefit.
This study concludes that there is insufficient evidence for routine use of
IVIG as an adjunct to standard therapies in neonatal sepsis as there was no
significant reduction of morbidity and mortality in the study population
following its administration.
Key Word :
Neonatal sepsis
IVIG Treatment.